Laurion Capital Management LP Moderna, Inc. Transaction History

Laurion Capital Management LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$101.21 - $166.61 $388,646 - $639,782	3,840 New	3,840 $456,000
Q4 2023 Feb 14, 2024	BUY	$69.51 - $104.43 $2.28 Million - $3.43 Million	32,800 New	32,800 $3.26 Million
Q2 2022 Aug 15, 2022	BUY	$117.13 - $176.59 $336,280 - $506,989	2,871 New	2,871 $410,000
Q1 2022 May 16, 2022	SELL	$126.46 - $235.05 $132,530 - $246,332	-1,048 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$225.82 - $368.51 $236,659 - $386,198	1,048 New	1,048 $266,000
Q2 2020 Aug 14, 2020	SELL	$29.67 - $80.0 $9.05 Million - $24.4 Million	-304,900 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$17.78 - $31.58 $5.42 Million - $9.63 Million	304,900 New	304,900 $9.13 Million
Q4 2019 Feb 13, 2020	SELL	$13.93 - $21.28 $457,168 - $698,388	-32,819 Closed	0 $0
Q3 2019 Nov 13, 2019	SELL	$12.26 - $18.07 $1.22 Million - $1.8 Million	-99,600 Reduced 75.22%	32,819 $522,000
Q2 2019 Aug 13, 2019	SELL	$13.7 - $28.34 $1.61 Million - $3.33 Million	-117,581 Reduced 47.03%	132,419 $1.94 Million
Q4 2018 Feb 14, 2019	BUY	$13.52 - $18.8 $3.38 Million - $4.7 Million	250,000 New	250,000 $3.82 Million

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.